Logo image of VROY.CA

VIZSLA ROYALTIES CORP (VROY.CA) Stock Fundamental Analysis

Canada - TSX-V:VROY - CA92859L2012 - Common Stock

3.78 CAD
+0.02 (+0.53%)
Last: 9/24/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to VROY. VROY was compared to 808 industry peers in the Metals & Mining industry. While VROY has a great health rating, there are worries on its profitability. VROY is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year VROY has reported negative net income.
In the past year VROY has reported a negative cash flow from operations.
VROY.CA Yearly Net Income VS EBIT VS OCF VS FCFVROY.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 2025 0 -1M -2M -3M

1.2 Ratios

The Return On Assets of VROY (-43.06%) is worse than 60.64% of its industry peers.
Looking at the Return On Equity, with a value of -43.67%, VROY is in line with its industry, outperforming 47.65% of the companies in the same industry.
Industry RankSector Rank
ROA -43.06%
ROE -43.67%
ROIC N/A
ROA(3y)-33.45%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VROY.CA Yearly ROA, ROE, ROICVROY.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 2025 0 -20 -40 -60

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for VROY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VROY.CA Yearly Profit, Operating, Gross MarginsVROY.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 2025

More info and screens

8

2. Health

2.1 Basic Checks

VROY has more shares outstanding than it did 1 year ago.
There is no outstanding debt for VROY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VROY.CA Yearly Shares OutstandingVROY.CA Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2025 10M 20M 30M
VROY.CA Yearly Total Debt VS Total AssetsVROY.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 2025 2M 4M 6M

2.2 Solvency

VROY has an Altman-Z score of 1375.38. This indicates that VROY is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 1375.38, VROY belongs to the best of the industry, outperforming 99.75% of the companies in the same industry.
VROY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1375.38
ROIC/WACCN/A
WACCN/A
VROY.CA Yearly LT Debt VS Equity VS FCFVROY.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 2025 0 2M 4M 6M

2.3 Liquidity

A Current Ratio of 71.03 indicates that VROY has no problem at all paying its short term obligations.
VROY has a better Current ratio (71.03) than 98.64% of its industry peers.
VROY has a Quick Ratio of 71.03. This indicates that VROY is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 71.03, VROY belongs to the best of the industry, outperforming 98.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 71.03
Quick Ratio 71.03
VROY.CA Yearly Current Assets VS Current LiabilitesVROY.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 2025 2M 4M 6M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for VROY have decreased strongly by -1921.54% in the last year.
EPS 1Y (TTM)-1921.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-667.69%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 65.87% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y68.92%
EPS Next 2Y26.95%
EPS Next 3Y65.87%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VROY.CA Yearly Revenue VS EstimatesVROY.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2M 4M 6M 8M
VROY.CA Yearly EPS VS EstimatesVROY.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0 0.05 -0.05 0.1 -0.1 0.15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VROY. In the last year negative earnings were reported.
Also next year VROY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VROY.CA Price Earnings VS Forward Price EarningsVROY.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VROY.CA Per share dataVROY.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1

4.3 Compensation for Growth

A more expensive valuation may be justified as VROY's earnings are expected to grow with 65.87% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.95%
EPS Next 3Y65.87%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VROY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VIZSLA ROYALTIES CORP

TSX-V:VROY (9/24/2025, 7:00:00 PM)

3.78

+0.02 (+0.53%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-23 2025-07-23/amc
Earnings (Next)N/A N/A
Inst Owners7.14%
Inst Owner ChangeN/A
Ins Owners2.85%
Ins Owner ChangeN/A
Market Cap253.22M
Analysts80
Price Target3.95 (4.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)34.78%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)50%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 32.75
P/tB 32.75
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.12
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -43.06%
ROE -43.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-33.45%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 71.03
Quick Ratio 71.03
Altman-Z 1375.38
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1921.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-667.69%
EPS Next Y68.92%
EPS Next 2Y26.95%
EPS Next 3Y65.87%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1822.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year25%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-437.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-437.28%
OCF growth 3YN/A
OCF growth 5YN/A